Breaking News

Thursday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Recommendations
Verano Holdings price target lowered to C$23 from C$24.50 at Canaccord » 13:13
05/26/22
05/26
13:13
05/26/22
13:13
VRNOF

Verano Holdings

$7.55 /

+0.37 (+5.15%)

Canaccord analyst Matt…

Canaccord analyst Matt Bottomley lowered the firm's price target on Verano Holdings to C$23 from C$24.50 and keeps a Buy rating on the shares.

ShowHide Related Items >><<
VRNOF Verano Holdings
$7.55 /

+0.37 (+5.15%)

VRNOF Verano Holdings
$7.55 /

+0.37 (+5.15%)

04/28/22 Canaccord
Verano Holdings price target lowered to C$24.50 from C$26 at Canaccord
02/11/22 Alliance Global Partners
Verano Holdings initiated with a Buy at Alliance Global Partners
02/09/22 Needham
Verano Holdings initiated with a Buy at Needham
02/01/22 Craig-Hallum
Goodness Growth downgraded to Hold from Buy at Craig-Hallum
VRNOF Verano Holdings
$7.55 /

+0.37 (+5.15%)

VRNOF Verano Holdings
$7.55 /

+0.37 (+5.15%)

On The Fly
Rising High: Exclusive talk with cannabis company Tyson 2.0 » 11:42
05/26/22
05/26
11:42
05/26/22
11:42
CMPS

Compass Pathways

$7.97 /

+0.215 (+2.77%)

, ATAI

Atai Life Sciences

$4.01 /

+0.175 (+4.56%)

, RLMD

Relmada Therapeutics

$19.11 /

-0.08 (-0.42%)

, ZYNE

Zynerba

$1.01 /

+0.08 (+8.60%)

, TCNNF

Trulieve Cannabis

$14.12 /

-0.2871 (-1.99%)

, TLRY

Tilray

$4.63 /

+0.19 (+4.28%)

, IGC

India Globalization Capital

/

+

, GTBIF

Green Thumb Industries

$11.85 /

-0.24 (-1.99%)

, GDNSF

Goodness Growth

$1.53 /

+0.05 (+3.38%)

, CANN

General Cannabis

/

+

, CRON

Cronos Group

$3.13 /

+0.085 (+2.79%)

, CGC

Canopy Growth

$5.35 /

+0.315 (+6.26%)

, CTST

CannTrust

/

+

, CVSI

CV Sciences

/

+

, ACB

Aurora Cannabis

$2.75 /

+0.07 (+2.62%)

, CCHWF

Columbia Care

$2.03 /

+0.05 (+2.53%)

In this edition of…

ShowHide Related Items >><<
ZYNE Zynerba
$1.01 /

+0.08 (+8.60%)

TLRY Tilray
$4.63 /

+0.19 (+4.28%)

TCNNF Trulieve Cannabis
$14.12 /

-0.2871 (-1.99%)

RLMD Relmada Therapeutics
$19.11 /

-0.08 (-0.42%)

IGC India Globalization Capital
/

+

GTBIF Green Thumb Industries
$11.85 /

-0.24 (-1.99%)

GDNSF Goodness Growth
$1.53 /

+0.05 (+3.38%)

CVSI CV Sciences
/

+

CTST CannTrust
/

+

CRON Cronos Group
$3.13 /

+0.085 (+2.79%)

CMPS Compass Pathways
$7.97 /

+0.215 (+2.77%)

CGC Canopy Growth
$5.35 /

+0.315 (+6.26%)

CCHWF Columbia Care
$2.03 /

+0.05 (+2.53%)

ATAI Atai Life Sciences
$4.01 /

+0.175 (+4.56%)

ACB Aurora Cannabis
$2.75 /

+0.07 (+2.62%)

CMPS Compass Pathways
$7.97 /

+0.215 (+2.77%)

02/28/22 Canaccord
Compass Pathways price target lowered to $78 from $80 at Canaccord
11/11/21 Roth Capital
Atai Life Sciences initiated with a Buy at Roth Capital
11/09/21 Citi
Citi says Compass Pathways selloff overdone, ups price target to $70
11/09/21 Cantor Fitzgerald
Compass Pathways price target raised to $82 from $71 at Cantor Fitzgerald
ATAI Atai Life Sciences
$4.01 /

+0.175 (+4.56%)

05/17/22 Citi
Atai Life Sciences price target lowered to $22 from $26 at Citi
04/01/22 Canaccord
Atai Life Sciences price target lowered to $27 from $28 at Canaccord
03/31/22 RBC Capital
Atai Life Sciences price target lowered to $9 from $12 at RBC Capital
11/30/21
Fly Intel: Top five analyst initiations
RLMD Relmada Therapeutics
$19.11 /

-0.08 (-0.42%)

05/09/22 Oppenheimer
Relmada Therapeutics price target lowered to $64 from $75 at Oppenheimer
12/20/21 SVB Leerink
Relmada Therapeutics price target lowered to $42 from $50 at SVB Leerink
11/17/21 Mizuho
Relmada Therapeutics initiated with a Buy at Mizuho
09/30/21 Jefferies
Jefferies says Street discounting importance of Relmada's Phase 2 mono MDD study
ZYNE Zynerba
$1.01 /

+0.08 (+8.60%)

04/01/22 Alliance Global Partners
Senate remains the hurdle for MORE Act, says Alliance Global Partners
06/25/21 Alliance Global Partners
Cannabis selloff brings buying opportunities, says Alliance Global
TCNNF Trulieve Cannabis
$14.12 /

-0.2871 (-1.99%)

05/12/22 Alliance Global Partners
Trulieve Cannabis price target lowered to C$50 from C$60 at Alliance Global Partners
03/31/22 Canaccord
Trulieve Cannabis price target lowered to C$65 from C$70 at Canaccord
03/30/22 Alliance Global Partners
Trulieve Cannabis price target lowered to C$60 from C$76 at Alliance Global Partners
TLRY Tilray
$4.63 /

+0.19 (+4.28%)

05/02/22 Alliance Global Partners
Tilray price target lowered to $5.50 from $8 at Alliance Global Partners
04/20/22 Barclays
Tilray price target lowered to $4.50 from $8.50 at Barclays
04/06/22 MKM Partners
Tilray margins contracted despite cost savings, says MKM Partners
04/06/22 Benchmark
Tilray fiscal Q3 results 'disappointing,' says Benchmark
IGC India Globalization Capital
/

+

GTBIF Green Thumb Industries
$11.85 /

-0.24 (-1.99%)

05/05/22 Alliance Global Partners
Green Thumb price target lowered to C$38 from C$40 at Alliance Global
05/05/22 Craig-Hallum
Green Thumb Industries price target lowered to $25 from $35 at Craig-Hallum
05/05/22 Needham
Green Thumb Industries price target lowered to $26 from $33 at Needham
GDNSF Goodness Growth
$1.53 /

+0.05 (+3.38%)

05/12/22 Canaccord
Goodness Growth price target lowered to C$3.50 from C$4 at Canaccord
02/01/22 Craig-Hallum
Goodness Growth downgraded to Hold from Buy at Craig-Hallum
11/11/21 Canaccord
Goodness Growth price target lowered to C$2.75 from C$4.50 at Canaccord
CANN General Cannabis
/

+

CRON Cronos Group
$3.13 /

+0.085 (+2.79%)

05/11/22 CIBC
CIBC upgrades Cronos to buy on 'multiple reasons for optimism'
05/11/22 Canaccord
Cronos upgraded to Hold on operational improvements at Canaccord
05/11/22 CIBC
Cronos Group upgraded to Outperformer from Neutral at CIBC
05/11/22 Canaccord
Cronos Group upgraded to Hold from Sell at Canaccord
CGC Canopy Growth
$5.35 /

+0.315 (+6.26%)

05/20/22 Alliance Global Partners
Canopy Growth price target lowered to C$8 from C$11 at Alliance Global Partners
04/04/22 Morgan Stanley
Constellation Brands price target lowered to $294 from $299 at Morgan Stanley
03/22/22 Barclays
Canopy Growth downgraded to Underweight from Equal Weight at Barclays
CTST CannTrust
/

+

CVSI CV Sciences
/

+

ACB Aurora Cannabis
$2.75 /

+0.07 (+2.62%)

05/16/22 CIBC
Aurora Cannabis price target lowered to C$3.75 from C$6.50 at CIBC
05/13/22 Cantor Fitzgerald
Aurora Cannabis price target lowered to C$3.90 from C$7.60 at Cantor Fitzgerald
02/11/22 Cantor Fitzgerald
Aurora Cannabis price target lowered to C$7.60 from C$10.75 at Cantor Fitzgerald
CCHWF Columbia Care
$2.03 /

+0.05 (+2.53%)

05/18/22 Canaccord
Columbia Care price target lowered to C$4.50 from C$6 at Canaccord
05/16/22 Alliance Global Partners
Columbia Care price target lowered to C$8 from C$9 at Alliance Global Partners
03/24/22 Stifel
Cresco Labs downgraded to Hold from Buy at Stifel
02/07/22 Alliance Global Partners
Cannabis operators in PA could see near-term impact to sales, says AGP
ZYNE Zynerba
$1.01 /

+0.08 (+8.60%)

TLRY Tilray
$4.63 /

+0.19 (+4.28%)

TCNNF Trulieve Cannabis
$14.12 /

-0.2871 (-1.99%)

RLMD Relmada Therapeutics
$19.11 /

-0.08 (-0.42%)

GTBIF Green Thumb Industries
$11.85 /

-0.24 (-1.99%)

CVSI CV Sciences
/

+

CRON Cronos Group
$3.13 /

+0.085 (+2.79%)

CMPS Compass Pathways
$7.97 /

+0.215 (+2.77%)

CGC Canopy Growth
$5.35 /

+0.315 (+6.26%)

ATAI Atai Life Sciences
$4.01 /

+0.175 (+4.56%)

ACB Aurora Cannabis
$2.75 /

+0.07 (+2.62%)

  • 09
    Dec
  • 18
    Jun
ZYNE Zynerba
$1.01 /

+0.08 (+8.60%)

CRON Cronos Group
$3.13 /

+0.085 (+2.79%)

CMPS Compass Pathways
$7.97 /

+0.215 (+2.77%)

CGC Canopy Growth
$5.35 /

+0.315 (+6.26%)

CCHWF Columbia Care
$2.03 /

+0.05 (+2.53%)

TLRY Tilray
$4.63 /

+0.19 (+4.28%)

CRON Cronos Group
$3.13 /

+0.085 (+2.79%)

CGC Canopy Growth
$5.35 /

+0.315 (+6.26%)

ATAI Atai Life Sciences
$4.01 /

+0.175 (+4.56%)

ACB Aurora Cannabis
$2.75 /

+0.07 (+2.62%)

Hot Stocks
Verano Holdings announces opening of Zen Leaf Westover » 07:21
05/26/22
05/26
07:21
05/26/22
07:21
VRNOF

Verano Holdings

$7.55 /

+0.37 (+5.15%)

Verano Holdings announced…

Verano Holdings announced the opening of Zen Leaf Westover, the Company's second in West Virginia dispensary and 99th location nationwide, on Friday, May 27. Zen Leaf Westover, located at 871 Fairmont Road, is open Wednesday through Saturday from 11:00 a.m. to 7:00 p.m. and 10:00 a.m. to 4:00 p.m. on Sunday, local time. Zen Leaf Westover is located in Monongalia County, the third largest county in West Virginia, with a population of over 106,0002. The dispensary is conveniently located just over one mile from the Morgantown Mall and two miles from West Virginia University, which has a population of nearly 26,000 students. Across West Virginia, Verano has permits issued by West Virginia's Office of Medical Cannabis to operate a cultivation and processing facility, along with seven total medical cannabis dispensaries that are projected to continue to open throughout 2022, subject to customary approvals.

ShowHide Related Items >><<
VRNOF Verano Holdings
$7.55 /

+0.37 (+5.15%)

VRNOF Verano Holdings
$7.55 /

+0.37 (+5.15%)

04/28/22 Canaccord
Verano Holdings price target lowered to C$24.50 from C$26 at Canaccord
02/11/22 Alliance Global Partners
Verano Holdings initiated with a Buy at Alliance Global Partners
02/09/22 Needham
Verano Holdings initiated with a Buy at Needham
02/01/22 Craig-Hallum
Goodness Growth downgraded to Hold from Buy at Craig-Hallum
VRNOF Verano Holdings
$7.55 /

+0.37 (+5.15%)

VRNOF Verano Holdings
$7.55 /

+0.37 (+5.15%)

Wednesday
Hot Stocks
Tilt Holdings amends purchase, sale agreement for White Haven facility » 08:16
05/25/22
05/25
08:16
05/25/22
08:16
TLLTF

Tilt Holdings

/

+

, IIPR

Innovative Industrial Properties

$124.28 /

-4.665 (-3.62%)

TILT Holdings has signed…

TILT Holdings has signed an amendment to its previously announced definitive agreement to sell its White Haven, Pennsylvania facility. The Amendment allows TILT and Innovative Industrial Properties to extend the end of the investigational period of the transaction contemplated to a date that is on or before June 17, 2022. The outstanding diligence items include buyer's third-party reports, including a phase I environmental assessment, zoning report and survey, and the Preliminary Title Report for the property, all of which were ordered in a timely manner following the effective date of the Purchase Agreement, but due to unforeseen delays have not yet been received by the parties. The extension provides an additional 24 days for the receipt of the outstanding diligence items. The Company expects to complete this transaction before the end of the quarter. Since its acquisition in January 2019, the Company has operated the White Haven facility, located at 411 Susquehanna Street, and comprised of an approximately 40,000 square-foot building that includes cultivation, processing, and a product manufacturing lab, as Standard Farms LLC. More information is available in the Company's original press release, issued January 28, 2019.

ShowHide Related Items >><<
TLLTF Tilt Holdings
/

+

IIPR Innovative Industrial Properties
$124.28 /

-4.665 (-3.62%)

TLLTF Tilt Holdings
/

+

IIPR Innovative Industrial Properties
$124.28 /

-4.665 (-3.62%)

05/09/22 Craig-Hallum
Craig-Hallum upgrades Innovative Industrial Properties to Buy with $175 target
05/09/22 Craig-Hallum
Innovative Industrial Properties upgraded to Buy from Hold at Craig-Hallum
01/14/22 Piper Sandler
Innovative Industrial price target lowered to $285 from $290 at Piper Sandler
11/04/21 JMP Securities
Innovative Industrial Properties price target raised to $300 from $260 at JMP Securities
IIPR Innovative Industrial Properties
$124.28 /

-4.665 (-3.62%)

  • 01
    Apr
IIPR Innovative Industrial Properties
$124.28 /

-4.665 (-3.62%)

IIPR Innovative Industrial Properties
$124.28 /

-4.665 (-3.62%)

Earnings
Verano Holdings reports Q1 revenue $202M, consensus $299.39M » 07:08
05/25/22
05/25
07:08
05/25/22
07:08
VRNOF

Verano Holdings

$7.18 /

-0.32 (-4.27%)

Q1 2022 gross profit was…

Q1 2022 gross profit was $100M or 49% of revenue, compared to $54M in the first quarter 2021; excluding an M&A inventory step up and depreciation and amortization, gross margin was 61%, up 1% from Q4 2021 on a comparable basis. Net loss in the first quarter 2022 was $7M, compared to a loss of $2 million in the first quarter 2021. "I am proud of the financial and operational performance we achieved this quarter, including sustaining our signature industry-leading margins, despite facing substantial headwinds that have affected our industry and the broader economy," said George Archos, Verano Founder and Chief Executive Officer. "We remain focused on execution, evidenced by our continued retail footprint expansion, where we added seven locations in the first quarter, including our first Zen Leaf dispensary in West Virginia. Further, the April launch of adult-use sales in New Jersey generated significant and immediate growth in the state, which is representative of similar opportunities we are poised to capitalize on in future transitioning markets in our portfolio. This summer, we are excited to add Zen Leaf Neptune as an additional adult-use dispensary in a prime Jersey Shore location, and throughout the course of 2022, we will continue to invest back in our business through a number of cultivation construction and expansion projects. Overall, we are pleased by our progress in strategically positioning Verano to capitalize on anticipated growth in the second half of the year and beyond."

ShowHide Related Items >><<
VRNOF Verano Holdings
$7.18 /

-0.32 (-4.27%)

VRNOF Verano Holdings
$7.18 /

-0.32 (-4.27%)

04/28/22 Canaccord
Verano Holdings price target lowered to C$24.50 from C$26 at Canaccord
02/11/22 Alliance Global Partners
Verano Holdings initiated with a Buy at Alliance Global Partners
02/09/22 Needham
Verano Holdings initiated with a Buy at Needham
02/01/22 Craig-Hallum
Goodness Growth downgraded to Hold from Buy at Craig-Hallum
VRNOF Verano Holdings
$7.18 /

-0.32 (-4.27%)

VRNOF Verano Holdings
$7.18 /

-0.32 (-4.27%)

Monday
Hot Stocks
Verano reports dismissal of all claims in Nielsen arbitration » 07:09
05/23/22
05/23
07:09
05/23/22
07:09
VRNOF

Verano Holdings

$7.52 /

+0.47 (+6.67%)

The company said,…

The company said, "Verano Holdings notified the U.S. District Court for the District of Colorado of its complete victory in arbitration regarding various frivolous RICO claims brought by Nicholas Nielsen. The arbitrator dismissed all of Nielsen's claims with prejudice and awarded Verano nearly $100,000 in attorney's fees in the arbitration, further underscoring the groundless nature of the lawsuit. In his claims, originally brought in Federal Court but ultimately adjudicated on the merits in arbitration, Nielsen failed to disclose that he had pled guilty to a four-count felony indictment in the State of Arkansas for the blatantly illegal marijuana cultivation and production operation he ran out of his home. Nielsen's claims were a meritless effort to shift blame to Verano and more than fifty other defendants for his conviction, which was based on illegal activity in which he engaged on his own volition and without the knowledge or involvement of Verano or others. With operations in 13 states, all with highly regulated state-legalized cannabis programs, Verano is a leading, vertically integrated multi-state cannabis operator in the United States. This complete victory for Verano validates its vigorous efforts to defend itself from these false, baseless and defamatory allegations that struck at one of Verano's core foundational principles - strict compliance with applicable law."

ShowHide Related Items >><<
VRNOF Verano Holdings
$7.52 /

+0.47 (+6.67%)

VRNOF Verano Holdings
$7.52 /

+0.47 (+6.67%)

04/28/22 Canaccord
Verano Holdings price target lowered to C$24.50 from C$26 at Canaccord
02/11/22 Alliance Global Partners
Verano Holdings initiated with a Buy at Alliance Global Partners
02/09/22 Needham
Verano Holdings initiated with a Buy at Needham
02/01/22 Craig-Hallum
Goodness Growth downgraded to Hold from Buy at Craig-Hallum
VRNOF Verano Holdings
$7.52 /

+0.47 (+6.67%)

VRNOF Verano Holdings
$7.52 /

+0.47 (+6.67%)

Over a week ago
Hot Stocks
Verano Holdings announces opening of MUV Ocala » 07:33
05/19/22
05/19
07:33
05/19/22
07:33
VRNOF

Verano Holdings

$7.00 /

-0.17 (-2.37%)

Verano Holdings announced…

Verano Holdings announced the opening of MUV Ocala on Friday, May 20, the Company's 47th Florida dispensary and 98th nationwide. MUV Ocala, located at 3701 SW College Road, is open Monday through Saturday from 9:00 a.m. to 7:00 p.m. and Sunday from 11:00 a.m. to 5:00 p.m., local time. MUV Ocala is located in Marion County, a rapidly growing area that experienced a population increase of 13.5% from 2010 to 2021. Ocala was also recently named the sixth fastest-growing city in the United States.

ShowHide Related Items >><<
VRNOF Verano Holdings
$7.00 /

-0.17 (-2.37%)

VRNOF Verano Holdings
$7.00 /

-0.17 (-2.37%)

04/28/22 Canaccord
Verano Holdings price target lowered to C$24.50 from C$26 at Canaccord
02/11/22 Alliance Global Partners
Verano Holdings initiated with a Buy at Alliance Global Partners
02/09/22 Needham
Verano Holdings initiated with a Buy at Needham
02/01/22 Craig-Hallum
Goodness Growth downgraded to Hold from Buy at Craig-Hallum
VRNOF Verano Holdings
$7.00 /

-0.17 (-2.37%)

VRNOF Verano Holdings
$7.00 /

-0.17 (-2.37%)

Recommendations
Columbia Care price target lowered to C$4.50 from C$6 at Canaccord » 13:29
05/18/22
05/18
13:29
05/18/22
13:29
CCHWF

Columbia Care

$1.93 /

-0.02 (-1.03%)

Canaccord analyst Matt…

Canaccord analyst Matt Bottomley lowered the firm's price target on Columbia Care to C$4.50 from C$6 and keeps a Buy rating on the shares.

ShowHide Related Items >><<
CCHWF Columbia Care
$1.93 /

-0.02 (-1.03%)

CCHWF Columbia Care
$1.93 /

-0.02 (-1.03%)

05/16/22 Alliance Global Partners
Columbia Care price target lowered to C$8 from C$9 at Alliance Global Partners
03/24/22 Stifel
Cresco Labs downgraded to Hold from Buy at Stifel
02/07/22 Alliance Global Partners
Cannabis operators in PA could see near-term impact to sales, says AGP
11/15/21 Canaccord
Columbia Care price target lowered to C$13 from C$15 at Canaccord
CCHWF Columbia Care
$1.93 /

-0.02 (-1.03%)

Hot Stocks
Marimed awarded dispensary license in Ohio » 07:37
05/18/22
05/18
07:37
05/18/22
07:37
MRMD

Marimed

/

+

MariMed announced it had…

MariMed announced it had been awarded a provisional dispensary license, PDL, by the Ohio Board of Pharmacy. MariMed won this license in the Ohio lottery process. The license allows the Company to develop a medical dispensary in Tiffin, Ohio, located south of Toledo and home to the University of Bucharest and Tiffin University. Under the Ohio regulations, MariMed must complete the buildout and pass final inspection by February of 2023. "We are delighted to enter the medical cannabis program in Ohio," said Bob Fireman, Chief Executive Officer of MariMed. "We intend to seek additional opportunities to expand our cannabis operations in Ohio including the distribution of our award-winning branded products."

ShowHide Related Items >><<
MRMD Marimed
/

+

MRMD Marimed
/

+

09/15/21 Colliers
Marimed initiated with a Buy at Colliers
Recommendations
Columbia Care price target lowered to C$8 from C$9 at Alliance Global Partners » 16:33
05/16/22
05/16
16:33
05/16/22
16:33
CCHWF

Columbia Care

$1.95 /

+0.05 (+2.63%)

Alliance Global Partners…

Alliance Global Partners analyst Aaron Grey lowered the firm's price target on Columbia Care to C$8 from C$9 and keeps a Buy rating on the shares, noting that the company reported sales below his and Street estimates. Despite the sales miss, the company maintained its 2022 sales view, but continued consumer headwinds could cause sales to come in below current guidance, said Grey. However, he still views the company as well-positioned for the long-term given the company's assets in key U.S. states and the pending Cresco merger, Grey added.

ShowHide Related Items >><<
CCHWF Columbia Care
$1.95 /

+0.05 (+2.63%)

CCHWF Columbia Care
$1.95 /

+0.05 (+2.63%)

03/24/22 Stifel
Cresco Labs downgraded to Hold from Buy at Stifel
02/07/22 Alliance Global Partners
Cannabis operators in PA could see near-term impact to sales, says AGP
11/15/21 Canaccord
Columbia Care price target lowered to C$13 from C$15 at Canaccord
08/27/21 Cantor Fitzgerald
Columbia Care upgraded to Overweight from Neutral at Cantor Fitzgerald
CCHWF Columbia Care
$1.95 /

+0.05 (+2.63%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.